Level of evidence is decent, but may not be applicable to all racial, ethnic groups
The latest iteration of a certain IOL family (enVista, Bausch + Lomb) is receiving positive feedback from early surgical users.
Treatment of ophthalmoplegia depends largely on the degree of paresis—the fewer the number of muscles that are involved and the greater the degree of residual activity in the affected muscles, the greater the likelihood of successful surg
The 2017 Charles D. Kelman Lecture touched on three main areas—from the teaching of the phaco technique during the early years of phaco to use of phaco in glaucoma patients to the introduction of phaco to surgeons in developing countries.
All multifocal intraocular lenses (IOLs) are not created equal.
Presbyopia patients have changed. They are younger than ever, more active than ever before, and they have more treatment options than ever before.
'Teleglaucoma’ is feasible and can play a major role in blindness prevention. Telemedicine and teleglaucoma are going to be an important part of how physicians take care of patients in the United States and worldwide.
Clinicians need to weigh such factors as inflammation and IOP in determining when steroid therapy is beneficial in uveitic glaucoma.
Cystoid macular edema can permanently alter vision, so it is highly crucial to utilize best practices for treating the cataract surgery complication.
An update is provided on the latest developments for an evidence-based approach in mild to severe dry eye disease.